UroGen Reports Fourth Quarter and Full Year 2017 Financial Results
Go back to UroGen Reports Fourth Quarter and Full Year 2017 Financial Results| (NASDAQ: URGN) | Delayed: 42.31 +0.07 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.24 | 52 Week High | $ | |||
| Open | $43.13 | 52 Week Low | $ | |||
| Day High | $43.61 | P/E | N/A | |||
| Day Low | $41.60 | EPS | $ | |||
| Volume | 698,175 | |||||
